Leuplinforection and blood bilirubin increased Patient Reports March 20, 2010

Leuplinforection Side Effects Report #5214768-8
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hot flush, malignant neoplasm progression, prostate cancer stage iv. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.

Leuplinforection Side Effects Report #5197711-X
Leuplinforection side effect was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2006. Male patient, 67 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuplinforection. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cancer pain, gamma-glutamyltransferase increased, hepatic function abnormal, hot flush, malignant neoplasm progression. Leuplinforection dosage: 11.25 MG (11.25 MG, 1 IN 12 WK), SUBCUTANEOUS. During the same period patient was treated with CASODEX, DECADRON. Patient was hospitalized. Patient died.